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The constant region of the yl, y2 and y3 heavy chains of the human IgGl, IgG2 and IgG3 immunoglobulins 
carries antigenic determinants or Glm, G2m and G3m allotypes, which are genetic markers of these sub- 
classes. The exceptional presence on yl and y2 chains of Gm allotypes usually located on the CH3 domain 
of y3 shows an unexpected clustering of base changes and subsequent identity of short DNA sequences in 
the CH3 exon of the non-allelic yl, y2 and y3 genes. Such clusters of substitutions are not easily explained 
on the classical basis of point mutations. A gene conversion, which substituted a segment of the yl or y2 
gene with the homologous region of the non-allelic y3 gene, is more likely. Other examples of possible con- 
version involving the y genes are described. The conservation or the restoration of short sequences produced 
by the conversion events might be related to the biological properties of the constant region of the heavy 
chains. 
Gm aflotypic marker Haplotype Gene conversion ~~~rnan~ CH gene 
1. INTRODUCTION the homology in amino acid sequences of their 
products [l-7,16]. 
In the human immunoglobulin system there are The const~t region of the yl, ~2, ~3, cu2 and (5 
5 classes or isotypes - IgM, IgD, IgG, IgE and chains carry antigenic determinants, referred to as 
IgA - defined by isotypic antigenic determinants Glm, G2m, G3m, A2m and Em allotypes, which 
and the physico-chemical and biological activities are specific of each of the subclasses and represent 
of their heavy chains (u, 6, y, 6 and cy, respective- genetic markers for the respective genes. Of all the 
ly). Subclasses are also recognised in IgG (IgGl, immuno~obulin genes, the most polymorphic are 
IgG2, IgG3 and IgG4) and IgA (IgAl and IgA2) the y3 and then the yl genes 117-261. The Gm, 
according to the properties of the constant region A2m and Em markers, inherited in fixed combina- 
of the heavy chains (71, ~2, y3 and ~4; (~1 and a2, tions or haplotypes due to the close linkage be- 
respectively) [l-7]. The CH genes coding for the tween the y, a and e genes (fig.l), are useful tools 
constant region of the heavy chains are closely for the characterization of populations, analyses 
linked on chromosome 14 [f&9]. Their order - of disease associations, forensic medicine and for 
5’-~6-~3~l-~~l-ry1.....y2-y4-r-cu2-3’ - has been the study of heavy chain gene evolution. In- 
determined from the study of cosmid clones and heritance of unexpected and unusual sets of 
from the patterns of deletions [lo-151. These class allotypes are particularly interesting since they 
and subclass genes have been generated by duplica- reveal genetic events (point mutations, duplica- 
tions of a common ancestor. This was suggested by tions, deletions, exchanges of CH exons, hybrid 
96 
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genes.. ) which have occurred at the level of the The presence of such an uncommon and stable yl 
coding sequences [27-311. Here we postulate that allele was demonstrated by its regular transmission 
gene conversion is a major genetic event in the CH through 3 generations of a Tunisian family; one 
multigene family. child was even found to be homozygous. 
2. MATERIALS AND METHODS 
Serum samples from Lebanese and Tunisian 
people were collected and tested for the Gm and 
Am allotypes by the classical haemagglutination- 
inhibition method. The specific antisera and the 
relevant red cell coatings have been described 
[23,24]. The exceptional Gm phenotypes erved as 
starting point for family investigations to deter- 
mine unambiguously the unusual haplotypes. 
3. RESULTS AND DISCUSSION 
3.1. Occurrence of IgG3 allotypes in IgGI and 
IgG2 subclasses 
3.1.1. Converted yl and 72 genes with y3 
sequences 
A few years ago, we demonstrated the occur- 
rence of some human Gm allotypes in more than 
one subclass [24,32]: the Gm (g5 and v) antigenic 
determinants, usually located on the CH3 domain 
of y3 chains (33-351 (fig.l), were found on 71 
chains encoded by an unusual GZrna~gS*v*z yl gene. 
Recently, we found again the Gm(gS and v) an- 
tigenic determinants at an unusual location but, in 
this case, they were located on y2 molecules 
(unpublished). 
The unexpected presence of Gm(g.5 and v) on 
these yl and 72 chains revealed a surprising identi- 
ty of short DNA sequences, encoding Gm(g5 and 
v), in the CH3 exon of the non-allelic 73, yl and 
y2 genes. Such remarkable clustering of base 
changes within the yl and y2 genes appear to be 
much more frequent than the normal mutation 
rate. Moreover, they are not easily explained on 
the classical basis of random mutation unless it is 
postulated that the mutations were repeated at the 
same position(s) on 2 different genes. The 
hypothesis of an unequal intragenic crossover be- 
tween the homologous yl and y3 genes (1st exam- 
ple) (fig.2A) or between the y2 and y3 genes (2nd 
example) may be considered. However, once 
again, the abnorm~ly increased frequency of such 
recombination events seems to be unlikely. A bet- 
ter explanation is that, by a gene conversion event, 
a small region of the CH3 sequence of the yl or y2 
gene was substituted by the homologous region of 
the non-allelic y3 gene coding for the Gm(g5 and 
v) allotypes (fig.2B). 
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Fig.1. Prevalent haplotypes of the human y3, 71 and y2 heavy chain allotypes in severa populations. 
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Fig.2. Diagrams of unequal intragenic rossover and of conversion between yl and y3 genes. (A) Unequal intragenic 
crossing-over witbin the CH3 exon. [a) Chromosome carrying a hybrid y3yf gene but no normal 73 and yf genes. (b) 
Chromosome carrying a hybrid yl-y3 gene and normai y3 and yX genes, <IS) conversion of a part of the CH3 sequence 
of the Gm”,“yl gene by the homologous region of the Gm g’*g3*U*vy3 non-ailelic gene, 
In the first example (converted yl gene), the 
maximum extent of the coding DNA stretch in- 
volved in the conversion of the yf gene may be 
predicted since the unusual or converted yl chains 
still possess the Glm(a) allotype. This marker is 
related to the presence on usual yl chains of Asp 
and Leu residues at positions 356 and 358, respec- 
tively ft6,36]. Consequently, the converted CH3 
sequence in the 71 acceptor gene is downstream of 
codon 358. 
In the second example (converted y2 gene), it is 
not possible to delimit the 5’-end of the converted 
region since both the y2 and y3 genes carry the 
same nGIm(a) isoalfotype related to the presence 
of Glu and Met residues at positions 356 and 338, 
respectively [l&37,38]. The length of the con- 
verted CH3 sequence might be the same as in the 
first example; alternatively, it may be larger and 
include the entire CH3 exon. 
3.2. Absence of some IgG.? altotypes 
3.2.1. Converted y3 genes with no~-p~l~or~~~c 
yl, ~2 or ~4 sequences 
In the cases described above a short DNA region 
has been transferred in the direction 5 ’ -3 ’ , from 
the y3 donor gene to the yl and y2 acceptor genes 
to its right (fig.I). 
We must consider aIs0 the conversion of 
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pol~orphic y3 genes by non-polymorphic yl, y2 
and ~4 sequences located at their 3 ’ -terminal side. 
We have described previously, in 3 unrelated Tu- 
nisian families [24], unusual ~3 chains, 
phenotypically G3m(gl and u), lacking the 
G3m(gS and v) allotypes usually present on the 
CH3 domain of the G3m(gl,g5,u,v)~3 chains 
(fig.1). Several other examples of such y3 chains 
have been reported [34]. The absence of the 
G3m(g5 and v) allotypes on these y3 chains might 
be due to the conversion of the y3 CH3 coding 
region by the homologous sequences of either yl, 
y2 or y4 subclass gene which lack these allotypes. 
It is particularly intriguing that they are the same 
Gm(g5 and v) antigenic determinants which were 
unexpectedly found on the aforementioned con- 
verted yl and ~2 chains. It seems likely that 
specific sequences favour the conversion within the 
CH3 coding (and flanking non-coding) sequences 
of the G3mg’@*“,“y3 allele and that gene conver- 
sion occurs in both 5 ’ -3 ’ and 3 ’ -5 ’ directions, the 
CH1 htnge CHZ 
b’ b4 
CH3 exon of this y3 gene being either the donor or 
the acceptor of the sequence. 
3.3. Inter-allelic conversions 
3.3.1. Conversion between y3 allelic genes 
Gene conversion between y3 allelic genes may be 
responsible for situations already reported. An un- 
common Gntb1*b4,g5~u*vy3 gene has been found in a 
Tunisian family and transmitted through 3 genera- 
tions [24]. This unusual gene may be explained by 
a gene conversion between G3mbo~bi’b3’b4’b5*“,v and 
G3mg’~g5~“~‘, the most common y3 alleles among 
the Caucasoids, the CH3 exon of the first allele be- 
ing converted by the homologous sequences of the 
second allele (fig.3A). The converted sequence, en- 
coding Gm(g5 and v), might be, again, the same as 
that described earlier. 
3.3.2. Conversion between yl allelic genes 
An example of possible gene conversion between 
yl allelic genes is represented by an unusual and 
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Fig.3. Postulated conversion of allelic y genes. (A) Conversion of the CH3 exon of the usual 73 G3mMf*b’.b3,M*b5*u*v 
allele. (B) Conversion of the 3’-side of the CHl exon of the usual yl Glmzsa allele. 
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unexpected yl gene inherited by only 1 of the 10 
children in a Lebanese family [39] but absent from 
the genotypes of the parents. The phenotype of the 
child could not be explained by various combina- 
tions of maternal and paternal haplotypes. To ex- 
plain the unexpected presence of the Gm(f) an- 
tigenic determinant we must postulate either a 
recombination or a gene conversion during the 
maternal or paternal meiosis. A single equal or 
unequal crossover, the most likely of all the recom- 
bination events between the y3 and yl genes, must 
be excluded, at least during the maternal meiosis, 
for the following reasons: the Glm’yl allele and 
the A2m’a2 gene, both these located at the right of 
the G3mbo1b1,b3~“~b5~u~vy3 gene [lo], should have 
been transmitted together and the child should be 
homozygous A2m1/A2m’ (fig.4A and D), whereas 
she is heterozygous A2m’/A2m2. Due to the fact 
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Fig.4. Diagrams of postulated single and double-, equal and unequal-, inter- and intragenic rossovers during the 
maternal meiosis unable to explain the unexpected presence of Gm(f). The first (A) and the last (D) recombinant 
haplotypes were not observed, the others are unlikely. (A) Single qual intergenic crossover between the 73 and yl genes. 
(A.B) Double equal intergenic crossover between, on the one hand, the y3 and yl genes and, on the other, the yl and 
(~2 genes. (A.C) Double equal crossover, the first one between the 73 and yl genes and the second one within the yl 
gene. (D) Single unequal intergenic crossover. 
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that the a2 alleles have not been affected by the 
postulated recombination, an unlikely double in- 
tergenic crossover is required (fig.4AB). Further- 
more, if the unexpected Gm(f) antigenic determi- 
nant is supposed to be located on yl chains 
phenot~ic~ly Glm(a,f), a double equal in- 
tragenic crossover must even be postulated which 
is far more unlikely (fig.rtA,C). In contrast, the 
presence of Gm(f) on Glm(a and f)yl chains may 
be readily explained by a conversion of the 3 ‘-end 
of the CHl exon of the yl GZm”+’ allele by the se- 
quence encoding Glm(f) from the Glm’yl allele 
during the maternal meiosis (fig.3B). 
4. CONCLUSION 
In the examples described here and in the case of 
the Gm~c3) epitope found on y2 chains instead of 
y3 1321, the converted amino acid sequences have 
been mainly recognised due to the numerous and 
mutually exclusive allotypes of the polymorphic y3 
chains. Such uncommon chains are more often un- 
masked in consanguineous populations because of 
the increased frequency of individuals homo- 
zygous for the corresponding unusual alleles. 
Other gene-conversion events within the human 
immunoglobulin CH genes may occur, as 
demonstrated between the al and (~2 genes [40] but 
would be masked at the heterozygous state or 
because of absence either of antigenic deter- 
minants or of antibodies able to detect them. 
Monoclonal antibodies should allow us to find 
more converted chains, by detecting Gm allotypes 
unrecognized to date by the conventional anti- 
allotypes antibodies [41]. 
Two major points arise from these postulated 
gene conversions within the human im- 
munoglobulin CH genes. Firstly, to account for 
the frequency of clusters of substitutions much 
higher than the normal mutation rate and for the 
polarity effect favouring the conversion of one 
short sequence more than an adjacent one, the 
gene conversion model must assume that the DNA 
cutting and joining processes occur at specific 
sites. Some of the examples described here, involv- 
ing the same DNA region of a y3 gene, tend to con- 
firm the existence of such hot-spots. Some 
nucleotide sequences, which seem to be present in 
regions more susceptible to breakage and which 
can form Z-DNA have been proposed as sites of 
gene conversion and recombination events (for 
review see [42]). 
Secondly, the gene conversion explains the 
maintenance of homology between non-allelic 
genes of highly polymorphic’ 143-471 and of less 
~l~orp~c [#,48-501 multigene families. The 
converted sequences in the IgCH region genes 
could be related to the structural and biological 
properties of the constant region of the heavy 
chains and should be, therefore, located at posi- 
tions strongly selected for survival during the 
evolution. For example, these sequences might be 
those involved in the binding to the poly-Ig recep- 
tor, to the various Fc receptors and to the receptors 
for transepithelial transport of IgG across the 
placenta as well as in the binding to the first com- 
ponent of Complement. They might be also in- 
volved in the allotypic r~og~tion signals on the 
CH region of the B cell-surface immunoglobulins 
for the T and B lymphocyte cooperation necessary 
to the B cell antigen-driven differentiation. 
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